1. Home
  2. AXTI vs ASRT Comparison

AXTI vs ASRT Comparison

Compare AXTI & ASRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AXTI
  • ASRT
  • Stock Information
  • Founded
  • AXTI 1986
  • ASRT 1995
  • Country
  • AXTI United States
  • ASRT United States
  • Employees
  • AXTI N/A
  • ASRT N/A
  • Industry
  • AXTI Semiconductors
  • ASRT Biotechnology: Pharmaceutical Preparations
  • Sector
  • AXTI Technology
  • ASRT Health Care
  • Exchange
  • AXTI Nasdaq
  • ASRT Nasdaq
  • Market Cap
  • AXTI 94.4M
  • ASRT 79.1M
  • IPO Year
  • AXTI 1998
  • ASRT 1997
  • Fundamental
  • Price
  • AXTI $3.11
  • ASRT $0.80
  • Analyst Decision
  • AXTI Strong Buy
  • ASRT Strong Buy
  • Analyst Count
  • AXTI 4
  • ASRT 1
  • Target Price
  • AXTI $4.60
  • ASRT $3.00
  • AVG Volume (30 Days)
  • AXTI 659.6K
  • ASRT 265.0K
  • Earning Date
  • AXTI 10-30-2025
  • ASRT 08-11-2025
  • Dividend Yield
  • AXTI N/A
  • ASRT N/A
  • EPS Growth
  • AXTI N/A
  • ASRT N/A
  • EPS
  • AXTI N/A
  • ASRT N/A
  • Revenue
  • AXTI $86,080,000.00
  • ASRT $117,099,000.00
  • Revenue This Year
  • AXTI N/A
  • ASRT N/A
  • Revenue Next Year
  • AXTI $31.28
  • ASRT $5.84
  • P/E Ratio
  • AXTI N/A
  • ASRT N/A
  • Revenue Growth
  • AXTI N/A
  • ASRT N/A
  • 52 Week Low
  • AXTI $1.13
  • ASRT $0.51
  • 52 Week High
  • AXTI $3.29
  • ASRT $1.38
  • Technical
  • Relative Strength Index (RSI)
  • AXTI 65.96
  • ASRT 54.77
  • Support Level
  • AXTI $2.91
  • ASRT $0.78
  • Resistance Level
  • AXTI $2.95
  • ASRT $0.87
  • Average True Range (ATR)
  • AXTI 0.22
  • ASRT 0.03
  • MACD
  • AXTI 0.05
  • ASRT -0.00
  • Stochastic Oscillator
  • AXTI 85.37
  • ASRT 34.36

About AXTI AXT Inc

AXT Inc is a developer and producer of compound and single element semiconductor substrates, also known as wafers. The dominant substrates used in producing semiconductor chips and other electronic circuits are made from silicon. It is engaged in the design, development, manufacture, and distribution of high-performance compound semiconductor substrates and the sale of materials. The company provides alternative or specialty materials in the form of substrates or wafers, including compound and single-element substrates. Its compound substrates combine indium with phosphorous or gallium with arsenic. Geographically firm has its business presence across the region of Europe, Japan, Taiwan, China, North America, and the Asia Pacific from which China derives its maximum revenue to the company.

About ASRT Assertio Holdings Inc.

Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older and Zipsor, liquid-filled capsules for relief of mild to moderate pain.

Share on Social Networks: